---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/280527246.md"
description: "The Nasdaq Biotechnology Index rose over 2.6%, outperforming the broader US stock market. Among constituents, Sarepta Therapeutics surged 34.98%, Summit Therapeutics Plc. rose 15.53%, Enliven Therapeutics increased 14.06%, Upstream Bio gained 12.07%, Taysha Gene climbed 10.90%, Gossamer Bio advanced 10.61%, and Oruka Therapeutics was up 9.80%. Conversely, Aardvark Therapeutics fell 6.10%, ADMA Biologics dropped 15.23%, Anavex Life Sciences declined 34.61%, and Maze Therapeutics fell 35.24%"
datetime: "2026-03-25T20:50:10.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280527246.md)
  - [en](https://longbridge.com/en/news/280527246.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280527246.md)
generator: "portal-rs"
---

# 

The Nasdaq Biotechnology Index closed up over 2.6%, outperforming the broader US stock market index.

Among constituents, Sarepta Therapeutics closed up 34.98%, Summit Therapeutics Plc. rose 15.53%, Enliven Therapeutics increased 14.06%, Upstream Bio gained 12.07%, Taysha Gene climbed 10.90%, Gossamer Bio advanced 10.61%, and Oruka Therapeutics was up 9.80%.

Aardvark Therapeutics closed down 6.10%, ADMA Biologics fell 15.23%, Anavex Life Sciences declined 34.61%, and Maze Therapeutics dropped 35.24%.

### Related Stocks

- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [TSHA.US](https://longbridge.com/en/quote/TSHA.US.md)
- [ADMA.US](https://longbridge.com/en/quote/ADMA.US.md)
- [SMMT.US](https://longbridge.com/en/quote/SMMT.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [UPB.US](https://longbridge.com/en/quote/UPB.US.md)
- [ORKA.US](https://longbridge.com/en/quote/ORKA.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [AVXL.US](https://longbridge.com/en/quote/AVXL.US.md)
- [SRPU.US](https://longbridge.com/en/quote/SRPU.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [AARD.US](https://longbridge.com/en/quote/AARD.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [SRPT.US](https://longbridge.com/en/quote/SRPT.US.md)
- [RLFTF.US](https://longbridge.com/en/quote/RLFTF.US.md)

## Related News & Research

- [‘Open Your Eyes,’ Says Top Investor About Oracle Stock](https://longbridge.com/en/news/301160283.md)
- [Marvell Now Sees as Much as $90 Billion in Annual Sales by Fiscal 2031. Here's Why It's a Chip Stock to Buy.](https://longbridge.com/en/news/301114413.md)
- [Palantir vs. Oracle – Why Daniel Ives Says Buy One, Hold the Other](https://longbridge.com/en/news/301155464.md)
- [Broadcom's AI Revenue Is Growing at 221%. Here's Why Custom Chips Could Be a Bigger Business Than GPUs.](https://longbridge.com/en/news/301141333.md)
- [LIVE MARKETS-TSMC earnings could cause another round of consensus upgrades](https://longbridge.com/en/news/301145455.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**